sun pharma glp 1 receives DCGI approval for Noveltreat, positioning itself strongly in India's fast-growing GLP-1 weight-management and diabetes therapy market ahead of patent expiry in 2026. #SunPharma #PharmaceuticalIndustry #GLP1 #Semaglutide Balancing Gut Support Blend GLP-1 Therapies Drive Indian Pharma

Pogue, J

10.1172/JCI185001 241 RaoM.McDuffieE.SrivastavaS.PlaistedW.SachsC

Vitamin C merupakan antioksidan yang berguna melindungi sel dengan menyerang radikal bebas sehingga kadar glutation tidak berkurang, bahkan meningkat

In older adults, that can translate into weakness, falls, and loss of independence if they are not protecting muscle with protein and resistance work

To participate in a fast-growing but competitive and complicated market, GLP-1 originators will need to adopt a differentiated patient- and customer-centric strategy leveraging both internal and external resources to optimize product positioning, building brand equity, integrating software and device solutions beyond the drug itself, and exploring innovative channels

While our ancestors may not have understood the mechanisms, they clearly observed the benefits, Kresser says